<DOC>
	<DOCNO>NCT02607319</DOCNO>
	<brief_summary>The objective study determine effect Bemiparin , low molecular weight heparin , implantation rate woman unexplained recurrent implantation failure undergo IVF/ICSI treatment .</brief_summary>
	<brief_title>Low Molecular Weight Heparin Improve Pregnancy Outcome Patients With Recurrent Implantation Failure</brief_title>
	<detailed_description>Recurrent implantation failure ( RIF ) , defined failure conception follow three consecutive In Vitro Fertilization ( IVF ) cycle despite transfer good quality embryo , major cause distress amongst infertile couple . While factor underlie implantation failure many , case remain unexplained . In order improve pregnancy outcomes delivery rate woman unexplained RIF , various investigational treatment propose . The investigator propose prospective control randomized comparative study evaluate effect Bemiparin implantation rate woman unexplained RIF . A total 200 patient recruit randomized two group . The study group receive Bemiparin plus standard care ; control group receive standard care . Treatment start day follow embryo transfer continue 12 week gestation event pregnancy . The primary objective determine effect Bemiparin implantation rate woman unexplained recurrent implantation failure .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>History three consecutively fail In Vitro Fertilization ( IVF ) cycle embryo transfer . Normal uterine cavity ( assessed hysteroscopy HSG ) . Normal hormonal investigation : TSH , PRL , FBS . Normal acquired/inherited thrombophilia profile : LAC , ACA IgG/IgM , Prot S , Antithrombin III , beta2 glycoprotein , Factors V , II , MTHFR . Normal semen analysis mild/moderate male factor ( Total motile sperm count &gt; 5 million/ml and/or normal WHO morphology &gt; 20 % . Patient provide write informed consent . Evidence low ovarian reserve least one following : AMH ≤ 1,5 ng/mL and/or basal CD 3 FSH ≥ 10 mIU/mL and/or basal CD 3 Estradiol ≥ 60 ng/mL and/or previous egg collection yield ≤ 3 oocyte . Preexisting medical condition ( thyroid disease , diabetes mellitus , hypertension , pulmonary condition , cardiac condition… ) . Severe male factor infertility ( Total motile sperm count &lt; 5 million/ml and/or normal WHO morphology &lt; 20 % ) . Hypersensitivity Heparin derivative . Acquired thrombophilia . Active hemorrhage increase risk bleeding due impairment homeostasis . Severe impairment liver pancreatic function . Severe renal insufficiency ( Creatinine Clearance &lt; 30 ml/min ) . Injuries operation central nervous system , eye ear within last 2 month . Disseminated Intravascular Coagulation ( DIC ) attributable heparininduced thrombocytopenia . Acute bacterial endocarditis endocarditis lenta . Any organic lesion high risk bleeding ( e.g . : active peptic ulcer , hemorrhagic stroke , cerebral aneurysm cerebral neoplasm ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Recurrent Implantation Failure</keyword>
	<keyword>Implantation</keyword>
	<keyword>low molecular weight heparin</keyword>
	<keyword>In vitro Fertilization</keyword>
	<keyword>Assisted Reproductive Technology</keyword>
	<keyword>Pregnancy</keyword>
</DOC>